At @years postprimary vaccination , @ % , @ % , and @ % of subjects initially vaccinated with MenACWY-CRM ( n = @ ) showed hSBA titers @ against serogroups C , W-@ , and Y , respectively ; this was lower for serogroup A ( @ % ) .